You just read:

New Antibiotic VIBATIV®▼ (telavancin) Targets Public Health Priority MRSA Infections for People with Hospital-Acquired Pneumonia Across Europe

News provided by

Clinigen Group plc

18 Sep, 2014, 13:40 BST